Business View: Big pharma haunted by the spectre of Pinto
207470
Remember the Ford Pinto? It was a small car with a poorly located fuel tank, which happened to explode if someone went into the back of it.
149032
The stock is feeling some pain these days. However, this drugmaker has enough going for it that the illness shouldn&#39;t last. Amid nervousness over the future of Pfizer&#39;s arthritis pain treatment Celebrex and
92784
Pfizer, AstraZeneca and Eli Lilly - each disclosed serious problems with important medicines yesterday, throwing a spotlight on the fact that the $500 billion
493543
The company has some major issues, which weighed heavily on its recent IPO.
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.
262080
There are two problems at the FDA. The first is that the Fraud and Drug Administration clearly puts the protection of Big Pharma profits as its primary mission, rather than protecting the public from dangerous drugs.
708021
The pharma gives us its quest for bidders.
60786
The e-commerce giant's stock price has gone psycho.
8068
Drug makers are exploring the possibility of tying pharmaceutical prices to performance.
440113
Pharmacopeia presents at an investors' conference.
377721
Faced with the threat of generic competition, the company focuses its efforts on a new drug.
403625
Be very wary of biotech IPOs from companies lacking drugs.
51238
An experimental eye disease drug has been a boon to Eyetech Pharmaceuticals. But as the drug nears approval, many doctors are questioning its effectiveness.
764344
The anti-industry crusader targets pharmaceuticals.
362559
Drug investors may be wishing they could pop two pills and feel better in the morning. The latest headache hit last week when Pfizer joined the rash of drug companies announcing problems with their products.
220042
The discontinuation of Exubera, an inhaled insulin, is another black eye for Pfizer, the worldâs biggest drug company, which has sustained a series of recent reversals.
61150
The $500 billion drug industry is stumbling badly in its core business of finding new medicines, while aggressively marketing existing drugs.